Axonics Modulation Technologies Inc. (AXNX) Tops Q1 EPS by 18c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to Axonics Modulation Technologies Inc. (AXNX) Tops Q1 EPS by 18c

Axonics® Reports First Quarter 2020 Results

May 5, 2020 4:00 PM EDT

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction, today reported financial results for the first quarter 2020 and provided an update on operational initiatives.

Recent Business & Financial Highlights

Net revenue was $26.3 million in the first quarter of 2020, the first full quarter of commercial results following U.S. Food & Drug Administration (FDA) approval of the Axonics r-SNM® System in November 2019. Sales momentum accelerated... More